🇺🇸 FDA

Company profile · Sponsor

Immunocore

Immunocore Ireland Limited

E466EC3 · EMA pharma GB
Pipeline
5
Drugs
0
Patents
0

Quick answer

Immunocore (E466EC3) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E466EC3
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (5)

Search pipeline →

  1. IMC-M113V

    Immunocore

    Chronic HIV infection

    phase 2 small molecule active

    1 trial

  2. IMC-R117C

    Immunocore

    Cancer

    phase 2 small molecule active

    1 trial

  3. YERVOY 5 mg/ml concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion, KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion, DACARBAZINE

    Immunocore

    Previously untreated advanced uveal melanoma (UM)

    phase 2 small molecule active

    1 trial

  4. IMC-I109V Single Ascending Dose

    Immunocore

    Hepatitis B, Chronic

    phase 1 small molecule terminated

    1 trial

  5. Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers

    Immunocore

    Advanced PRAME Positive Cancers

    phase 1 other active

    1 trial

Frequently asked questions

What is Immunocore?

Immunocore (E466EC3) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Immunocore sponsor?

We track 5 ClinicalTrials.gov-linked programs for Immunocore, including IMC-M113V and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Immunocore company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.